MiMedx Group, Inc. Accrued Liabilities, Current
MiMedx Group, Inc. (MDXG) had Accrued Liabilities, Current of $11.14 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-07-29
- 2026-06-30: Accrued Liabilities, Current $11.14M.
- 2026-03-31: Accrued Liabilities, Current $11.01M.
- 2025-12-31: Accrued Liabilities, Current $11.38M.
- 2025-09-30: Accrued Liabilities, Current $12.82M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.14M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $11.01M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $11.38M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $12.82M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $15.11M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $9.45M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $9.01M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $8.40M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $9.28M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $9.20M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $9.36M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $9.44M 10-Q · filed 2023-10-30 | |
| 2023-06-30 | $12.64M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $13.04M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $10.93M 10-K · filed 2024-02-28 | $11.02M 10-K · filed 2023-02-28 |
| 2022-09-30 | $10.99M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $10.00M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $9.81M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $9.81M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $13.69M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $17.07M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $30.68M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $30.46M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $28.36M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $25.77M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $30.66M 10-Q · filed 2020-07-06 | |
| 2019-12-31 | $32.16M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $37.44M 10-Q · filed 2020-07-06 | |
| 2019-06-30 | $42.82M 10-Q · filed 2020-07-06 | |
| 2019-03-31 | $35.74M 10-Q · filed 2020-07-06 | |
| 2018-12-31 | $31.84M 10-K · filed 2020-07-06 | |
| 2017-12-31 | $15.77M 10-K · filed 2020-03-17 | |
| 2017-09-30 | $8.61M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $7.99M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $9.94M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $19.21M 10-K · filed 2020-03-17 | $10.94M 10-K · filed 2017-03-01 |
| 2016-09-30 | $6.66M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $6.99M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $5.14M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.64M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $4.10M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $3.73M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $3.62M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $2.50M 10-K · filed 2017-02-22 | |
| 2014-09-30 | $1.99M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.14M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.37M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.41M 10-K · filed 2015-03-13 | $1.41M 10-K · filed 2014-03-04 |
| 2013-09-30 | $1.41M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.08M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.23M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $990.70K 10-K · filed 2014-03-04 | $3.74M 10-K · filed 2013-03-15 |
| 2011-12-31 | $783.19K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |